
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.850 | 5.850 | 0.000 |
Stocks | 94.110 | 94.110 | 0.000 |
Bonds | 0.030 | 0.070 | 0.040 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.385 | 20.453 |
Price to Book | 3.792 | 4.071 |
Price to Sales | 3.655 | 2.455 |
Price to Cash Flow | 17.238 | 16.429 |
Dividend Yield | 1.495 | 1.361 |
5 Years Earnings Growth | 10.350 | 12.134 |
Number of long holdings: 59
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 5.98 | 818.22 | +1.61% | |
Thermo Fisher Scientific | US8835561023 | 4.55 | 489.06 | +1.26% | |
J&J | US4781601046 | 4.16 | 155.36 | +1.38% | |
UnitedHealth | US91324P1021 | 3.49 | 523.20 | +0.02% | |
Novartis | CH0012005267 | 3.43 | 96.82 | -1.63% | |
AbbVie | US00287Y1091 | 3.25 | 205.19 | -0.52% | |
Novo Nordisk B | DK0062498333 | 3.17 | 466.6 | -2.59% | |
Sanofi | FR0000120578 | 3.07 | 100.40 | -1.59% | |
Lonza Group | CH0013841017 | 2.75 | 532.00 | -1.77% | |
IQVIA Holdings | US46266C1053 | 2.57 | 174.37 | +1.83% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FR0013073731 | 703.01M | 9.67 | 6.49 | 5.41 | ||
FR0013446812 | 94M | -2.76 | -15.66 | - | ||
FR0013083656 | 35.12M | 5.96 | 3.35 | 3.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review